**Pathophysiology** (_Clin Physio Acid-Base_ 2001; _CJASN_ 2008;3:1861)

•Saline-responsive etiologies require _initiating event_ and _maintenance phase_

•_Initiating event:_ net HCO3− reabsorption (due to loss of volume, Cl-, and/or K+) or loss of H+

**Loss of H+** (± Cl-) from GI tract, kidneys, or transcellular shift in hypokalemia

**Contraction alkalosis:** loss of HCO3--poor fluid → extracellular fluid “contracts” around fixed amount of HCO3- → ↑ HCO3- concentration

**Exogenous alkali:** iatrogenic HCO3- (with renal impairment), milk-alkali syndrome

**Posthypercapnia:** resp. acidosis → compensation with H+ excretion and HCO3- retention; rapid correction of hypercapnia (eg, intubation) → transient excess HCO3-

•_Maintenance phase_

**Volume depletion** → ↑ ATII → ↑ PCT reabsorption of HCO3- & ↑ aldosterone (see below)

**Cl**- **depletion** → ↓ Cl- uptake in macula densa → ↑ RAS & ↑ CCD Cl-/HCO3- exchanger

**Hypokalemia** → transcellular K+/H+ exchange; intracellular acidosis → HCO3- reabsorption and ammoniagenesis & ↑ distal H+-K+-ATPase activity → HCO3- retention

**Hyperaldosteronism** (1° or 2°) → ↑ CCD α-intercalated H+ secretion w/ HCO3- retention & Na+ reabsorption in principal cell → H+ secretion (for electrical neutrality)

![](https://i.imgur.com/n5cpR93.png)

**Workup**

•Check **volume status** and **U****Cl**

UCl <25 mEq/L → saline responsive

UCl >40 mEq/L → saline resistant (unless currently receiving diuretics)

(UNa unreliable determinant of volume status in alkalemia → ↑ HCO3- excretion → ↑ Na excretion; negatively charged HCO3- w/ Na+ maintaining electrical neutrality)

If UCl >40 and volume replete, ✔ UK; UK < 20 laxative abuse; UK >30, ✔ **blood pressure**

![](https://i.imgur.com/qqfu9zr.png)

**Treatment of severe metabolic alkalosis (pH** >**7.6)** (_JASN_ 2012;23:204)

•If saline responsive: resuscitate with Cl-rich solution (NS), replete K, d/c diuretics cardiopulmonary disease precludes hydration, can use KCl, acetazolamide, HCl

•If NGT drainage that cannot be stopped: PPI or H2-blocker (_Clin Nephro_ 2006;66:391)

•Hyperaldosteronism: treat underlying condition, K-sparing diuretic, resect adenoma if 1o